IMS Announces Pan-European Agreement With GlaxoSmithKline

    Business Editors/Health Editors/Science Editors

    LONDON--(BUSINESS WIRE)--April 20, 2005--IMS Health (NYSE:RX), the world's leading provider of information solutions to the pharmaceutical and healthcare industries, today announced an agreement to collaborate with GlaxoSmithKline (GSK) on a programme to improve management of sales force information in GSK's pharmaceuticals business in Europe. The financial terms of the agreement were not disclosed.
    "We are pleased to strengthen our long-standing relationship with GSK and to support them in this significant engagement," said Gilles Pajot, IMS executive vice president and president, IMS EMEA Region. "In today's competitive and complex marketplace, pharmaceutical companies are looking to enhance the productivity of their sales teams and to deliver higher returns on investments in R&D and new products. IMS's powerful combination of information, analytics and consulting capabilities will enable us to help GSK achieve its business objectives."
    "At GSK, high-quality information and analytics are important in informing our business decisions," said Angelos Papadimitriou, vice president, European Commercial Development, GSK Pharmaceuticals Europe. "We are pleased to work with IMS to further develop our capabilities in this area."

    About IMS

    Operating in more than 100 countries, IMS Health is the world's leading provider of information solutions to the pharmaceutical and healthcare industries. With USD 1.6 billion in 2004 revenue and more than 50 years of industry experience, IMS offers leading-edge business intelligence products and services that are integral to clients' day-to-day operations, including portfolio optimization capabilities; launch and brand management solutions; sales force effectiveness innovations; managed care and over-the-counter offerings; and consulting and services solutions that improve ROI and the delivery of quality healthcare worldwide. Additional information is available at http://www.imshealth.com.

    About GlaxoSmithKline

    GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. Additional information is available at http://www.gsk.com.

--30--AM/ny*

CONTACT: IMS Health Cathy Mitchell-Reid, +44 207 393 5130 CMitchell-Reid@uk.imshealth.com

KEYWORD: CONNECTICUT UNITED KINGDOM INTERNATIONAL EUROPE INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BANKING MARKETING AGREEMENTS SOURCE: IMS Health

Copyright Business Wire 2005